Nikhil Prasad Fact checked by:Thailand Medical News Team Feb 17, 2025 1 month, 5 days, 3 hours, 28 minutes ago
Medical News: A Century Old Vaccine with New Potential
The Bacillus Calmette-Guérin (BCG) vaccine has been widely used for over a century to protect against tuberculosis. However, researchers from the University of Lodz, the Medical University of Lodz, and the Lodz Centre of Molecular Studies on Civilisation Diseases in Poland have uncovered a surprising range of immunological benefits linked to this vaccine. Beyond its established role in tuberculosis prevention, the BCG vaccine has shown potential in reducing the impact of viral infections, autoimmune disorders, and even cancer. This
Medical News report explores the groundbreaking findings and what they mean for the future of medicine.
New insights into the immunological benefits of the BCG vaccine
The Mechanism Behind the Broad Protective Effects
Scientists have discovered that the BCG vaccine triggers a process called trained immunity. Unlike traditional vaccines that stimulate adaptive immunity, which involves long-term memory through antibodies and T cells, the BCG vaccine reprograms innate immune cells, such as monocytes and macrophages. This reprogramming enhances the body’s ability to respond to a wide range of infections by increasing immune cell activity and cytokine production. Studies have indicated that this effect can last for months or even years, providing broader protection against various diseases.
Potential Benefits Against Viral Infections
Several studies suggest that individuals who have received the BCG vaccine may be better protected against viral infections, including respiratory viruses like influenza and even COVID-19. A study conducted on mice demonstrated that BCG vaccination enhanced the response of immune cells in the lungs, leading to increased resistance against the influenza A virus. Additionally, clinical trials exploring BCG revaccination against COVID-19 have provided mixed results, with some showing reduced severity of symptoms, while others indicate no significant impact. Nevertheless, researchers continue to investigate how trained immunity can be harnessed for pandemic preparedness and respiratory disease management.
BCG As a Potential Therapy for Autoimmune Diseases
Autoimmune diseases occur when the immune system mistakenly attacks the body’s own tissues. The BCG vaccine has shown promise in reprogramming immune responses, which could help reduce inflammation and restore immune balance. Notably, research on multiple sclerosis (MS) has yielded encouraging results. Clinical trials have demonstrated that BCG vaccination reduces the number of active lesions in MS patients without adverse side effects.
Furthermore, early administration of the vaccine appears to delay disease progression by improving immune tolerance and regulating inflammation.
Another autoimmune condition under investigation is type 1 diabetes. Studies have suggested that repeated BCG vaccination could help reset immune responses in diabetic patients, reducing the autoimmune attack on insulin-producing cells. Although more extensive trials are needed, preliminary findings indi
cate that BCG could play a role in managing or even preventing some autoimmune diseases.
The Role of BCG in Cancer Treatment
The use of the BCG vaccine in cancer treatment is not new. It has been a standard therapy for non-muscle-invasive bladder cancer for decades. However, recent research suggests that its benefits may extend to other cancers, such as melanoma and lung cancer. Scientists have found that BCG induces an anti-tumor immune response by stimulating natural killer (NK) cells and cytotoxic T cells, which help attack cancer cells.
In lung cancer studies, intravenous BCG administration has been shown to activate immune cells, promoting anti-tumor effects. Moreover, combining BCG therapy with immune checkpoint inhibitors has enhanced the efficacy of cancer treatments in preclinical studies. While human trials are still underway, these findings highlight the potential of BCG as a powerful immunotherapeutic agent.
A Promising Future for BCG Research
The broad immunological effects of the BCG vaccine have sparked renewed interest among scientists, leading to ongoing clinical trials in various disease areas. Researchers are particularly focused on understanding how to optimize BCG-based therapies to maximize benefits while minimizing risks. The ability of the vaccine to enhance innate immune responses could lead to novel treatments for infectious diseases, autoimmune conditions, and cancer.
While challenges remain, including variability in individual responses and the need for further studies, the growing body of evidence suggests that the BCG vaccine is far more than just a tuberculosis shot. If future research confirms these findings, BCG-based therapies could revolutionize medicine by offering new ways to boost immune defenses and treat chronic diseases.
The study findings were published in the peer-reviewed journal: Pathogens.
https://www.mdpi.com/2076-0817/14/2/196
For the latest Vaccine News, keep on logging to Thailand
Medical News.
Read Also:
https://www.thailandmedical.news/news/study-by-u-s-national-institute-of-allergy-and-infectious-diseases-claims-bacille-calmette-guerin-vaccine-could-protect-against-covid-19-disease-sever
https://www.thailandmedical.news/news/californian-based-immunitybio-team-ups-with-serum-institute-of-india-to-end-merk-s-monopoly-on-bcg-vaccine-supply
https://www.thailandmedical.news/news/study-shows-that-tuberculosis-vaccine-decreases-rates-of-alzheimer-s-disease-in-individuals-with-bladder-cancer
https://www.thailandmedical.news/pages/thailand_doctors_listings
Follow us on:
https://x.com/ThailandMedicaX
https://www.facebook.com/ThailandMedicalNews
https://bsky.app/profile/thailandmedical.bsky.social
https://gettr.com/user/thailandmedicalnews
https://www.tribel.com/thailandmedical/wall
and 33 other social media platforms
Share
Tweet
Share
